| Identification | |
| Name: | Raltegravir potassium |
| Synonyms: | 4-Pyrimidinecarboxamide,N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-,monopotassium salt (9CI);Isentress;MK 0518; |
| CAS: | 871038-72-1 |
| Molecular Formula: | C20H21FN6O5.K |
| Molecular Weight: | 482.51 |
| InChI: | InChI=1/C20H21FN6O5.K/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11;/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30);/q;+1/p-1 |
| Molecular Structure: | ![(C20H21FN6O5.K) 4-Pyrimidinecarboxamide,N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5...](https://img.guidechem.com/casimg/871038-72-1.gif) |
| Properties | |
| Density: | 1.46 g/cm3 |
| Appearance: | Off-white solid |
| Specification: |
Raloxifene hydrochloride (CAS NO.871038-72-1) can be kept in well-closed glass bottle. |
| Usage: |
Raloxifene hydrochloride (CAS NO.871038-72-1) is commonly used as a potent human immunodeficiency virus (HIV) integrase inhibitor and a novel anti-AIDS drug. |
| Safety Data | |
 |
|
